Timing nalbuphine for pain relief and blood pressure control during knee replacement in older adults
Official title: Effects of Different Administration Timings of Nalbuphine on Hemodynamics and Postoperative Analgesia in Elderly Patients Undergoing Total Knee Arthroplasty
Run by Qianfoshan Hospital · NCT07271849 · Data updated 2026-11-12
We will test whether giving nalbuphine at different times during knee replacement helps control pain and stabilize blood pressure in people 65 and older.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years to 90 Years |
| Sex | All |
| Enrollment | 162 (estimated) |
| Sponsor | Qianfoshan Hospital Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | October 28, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | December 9, 2025 |
| Trial ID | NCT07271849 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 65 or older undergoing unilateral total knee arthroplasty under general anesthesia with BMI 18–30, ASA I–III, normal mental status, and no contraindications to nalbuphine.
✕Probably not a fit
Patients with uncontrolled hypertension, severe respiratory disease, significant liver or kidney dysfunction, or who fall outside the specified age or BMI ranges are unlikely to be eligible or benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase 4 interventional trial compares three approaches to perioperative nalbuphine use in elderly patients undergoing unilateral total knee arthroplasty under general anesthesia: nalbuphine at induction, nalbuphine after cement implantation, or standard care without nalbuphine. Investigators will monitor intraoperative hemodynamics, proxies for cerebral perfusion, postoperative pain scores, total opioid consumption, and opioid-related side effects such as nausea and vomiting. Eligible participants are adults aged 65 or older with BMI 18–30 and ASA physical status I–III who consent and meet laboratory criteria. The study aims to determine whether the timing of nalbuphine administration improves hemodynamic stability and reduces postoperative pain and opioid needs.
Why it matters
Potential benefit: If successful, timing nalbuphine appropriately could reduce pain and opioid use while improving blood pressure stability and cerebral perfusion during and after knee replacement in older patients.
How similar studies have gone: Prior clinical work shows nalbuphine provides effective postoperative analgesia with fewer mu-opioid side effects than morphine, but using specific timing to improve intraoperative hemodynamics in elderly TKA patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All study participants voluntarily enrolled in the trial and provided written informed consent after being fully informed of the trial's purpose and significance * Participants underwent unilateral total knee arthroplasty under general anesthesia * Elderly participants (age ≥ 65 years), regardless of gender * Body mass index (BMI) ranging from 18 kg/m² to 30 kg/m² * Absence of psychiatric disorders, normal consciousness, and ability to communicate effectively * American Society of Anesthesiologists (ASA) physical status classification I-III; * No contraindications to the study medications Exclusion Criteria: * Study participants with uncontrolled or untreated hypertension (resting systolic/diastolic blood pressure \>180/100 mmHg) * Individuals with severe respiratory diseases * Subjects with abnormal liver or renal function (ALT and/or AST \>2.5 times the upper limit of normal, total bilirubin \>1.5 times the upper limit of normal, serum creatinine \>1.5 times the upper limit of normal) * Individuals with a history of drug abuse, illicit drug use, or alcohol abuse, where alcohol abuse is defined as an average daily alcohol intake exceeding 2 units (1 unit = 360 mL of beer, 45 mL of 40% alcohol by volume spirits, or 150 mL of wine)
Where it's running
-
Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University,
Jinan, Shandong, China Recruiting
Study contacts
- Principal investigator: Guo Liang, Ph.D — Qianfoshan Hospital
- Study coordinator: Guo Liang, Ph.D
- Email: 2330guoliang@163.com
- Phone: 8617096838266
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suzetrigine for pain relief after knee replacement
This trial tests whether suzetrigine can reduce opioid use after a total knee replacement compared with placebo.
-
Postoperative Pain Control in Elderly Knee Replacement
This study tests two pain-management methods after knee replacement in adults 60 and older to see which one reduces delirium and improves recovery.
-
Anterior suprascapular nerve block vs interscalene block for shoulder surgery pain
This trial tests whether an anterior suprascapular nerve block can provide similar pain relief to the standard interscalene block after outpatient shoulder surgery in adults.
-
Compare TAP block vs ESP block for pain after laparoscopic kidney surgery
Adults undergoing laparoscopic renal surgery will try either a TAP block or an ESP block to see which one better controls pain after surgery.
-
Total IV anesthesia vs spinal anesthesia for same-day discharge after knee replacement
This study tests whether using total intravenous anesthesia (TIVA) or spinal anesthesia helps adults have same-day discharge after a primary total knee replacement.
-
Comfort Tote to help recovery after scoliosis surgery in teens
This study tests whether a therapeutic Comfort Tote can reduce pain and anxiety after surgery for adolescent idiopathic scoliosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.